Neostem Inc.

NeoStem, Inc. Names Edward Geehr, M.D. to Board of Directors; Biotechnology Executive Brings Scientific and Business Experience in Global Operations.
Cancer Weekly; 11/17/2009; 790 words; NeoStem, Inc. (NYSE Amex: NBS), announced that...delighted to join the Board of Directors of NeoStem Inc. This is an extraordinary, dynamic...Medicine, Oncology, Therapy, Treatment, NeoStem Inc. This article was prepared by Cancer...

NeoStem Acquires China Biopharmaceuticals Holdings, Inc.; Obtains Controlling Interest in Profitable Leading Chinese Pharmaceutical Company.
Biotech Week; 11/11/2009; 774 words; NeoStem, Inc. (NYSE Amex: NBS), announced that...Biopharmaceuticals, China Biopharmaceuticals Holdings Inc., Drugs, Marketing and Licensing Agreements...Company, Pharmaceuticals, Therapies, NeoStem Inc. This article was prepared by Biotech...

NEOSTEM REPORTS MULTIPLE TRANSACTIONS BY DIRECTOR BERNSTEIN (New York)
US Fed News Service, Including US State News; 11/7/2009; 305 words; WASHINGTON, Nov. 7 -- NeoStem Inc. (NBS), New York, has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial interest...

NEOSTEM REPORTS ACQUISITION BY VP VACZY (New York)
US Fed News Service, Including US State News; 11/7/2009; 304 words; WASHINGTON, Nov. 7 -- NeoStem Inc. (NBS), New York, has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial interest...

NEOSTEM REPORTS ACQUISITION BY DIRECTOR WEI (New York)
US Fed News Service, Including US State News; 11/7/2009; 300 words; WASHINGTON, Nov. 7 -- NeoStem Inc. (NBS), New York, has filed a Form 4 with the Securities and Exchange Commission noting the change in the beneficial interest...